We used clinical data presented in (the Cancer Genome Atlas Program) TCGA to extend this research and investigate if a correlation between overexpression of MDM2 gene and a decrease in patient survival is found in any of the molecular subtypes of breast cancer. The gene discussed is MDM2; the disease is breast carcinoma.